Biaryl heterocycle substituted oxazolidinone antibacterial agents
AssigneeXuanzhu Pharma Co., Ltd.
InventorsFrank Wu, Aichen Wang
Life of this patent
Estimating the term…
Abstract
The present invention relates to a biaryl heterocycle substituted oxazolidinone antibacterials shown by general formula (I), a pharmaceutically acceptable salt thereof, an isomer or a prodrug thereof, wherein R1, R2, R3, R4, R5, A and B are as defined in the description. The present invention further relates to a method for preparing the compound, a pharmaceutical composition and a pharmaceutical formulation comprising the compound, and a use of the compound in the manufacture of a medicament for the treatment and/or prevention of infectious diseases and a use for the treatment and/or prevention of infectious diseases.
Claims12
A compound of general formula (I), a pharmaceutically acceptable salt thereof, an isomer thereof or a prodrug thereof,
- wherein,
- R1 is selected from (1) —OR6, (2) —NR6R6′, (3) —COR6, (4) —COOR6, (5) —OCOR6, (6) —CONR6R6′, (7) —NR6COR6′, (8) —OCONR6R6′, (9) —NR6COOR6′, (10) —NR6CONR6′R6, (11) —CSR6, (12) —CSOR6, (13) —OCSR6, (14) —CSNR6R6′, (15) —NR6CSR6′, (16) —OCSNR6R6′, (17) —NR6CSOR6′, (18) —NR6CSNR6′R6, (19) —NR6C(NR6)NR6′R6, (20) —S(O)pR6, (21) —SO2NR6R6′, or (22) R6,
- p is 0, 1 or 2,
- R6, R6′ are independently selected from:
- (1) hydrogen, (2) C1-6 alkyl, (3) C2-6 alkenyl, (4) C2-6 alkynyl, (5) 3-14 membered cycloalkyl, (6) 6-14 membered aryl, (7) 3-14 membered heterocyclyl, containing one or more heteroatoms selected from N, S, O and/or SO2, (8) —COC1-6 alkyl, (9) —COC2-6 alkenyl, or (10) —COC2-6 alkynyl;
- R2, R3 are independently selected from hydrogen, halogen or C1-6 alkyl;
- A is selected from
- B is selected from
- wherein X, Y, W, Z are each independently selected from C atom or N atom, and Q is independently selected from CH2, NH, O atom or S atom;
- R4 is selected from:
- (1) hydrogen, (2) C1-6 alkyl, (3) C2-6 alkenyl, (4) C2-6 alkynyl, (5) 3-14 membered cycloalkyl, (6) 6-14 membered aryl, (7) 3-14 membered heterocyclyl, containing one or more heteroatoms selected from N, S, O and/or SO2, (8) —COC1-6 alkyl, (9) —COC2-6 alkenyl, or (10) —COC2-6 alkynyl;
- R5 is selected from the following groups which are unsubstituted or substituted by 1-3 R7:
- (1) 3-14 membered cycloalkyl,
- (2) 6-14 membered aryl,
- (3) 3-14 membered heterocyclyl, or
- (4) 5-14 membered heteroaryl,
- R7 is selected from halogen, carboxyl, hydroxyl, amino, cyano, nitro, C1-6 alkyl, carboxyl C1-6 alkyl, hydroxyl C1-6 alkyl, amino C1-6 alkyl, halo C1-6 alkyl, C1-6 alkoxyl, halo C1-6 alkoxyl, C1-6 alkoxyl C1-6 alkyl, C1-6 alkyl amino, di(C1-6 alkyl)amino, di(C1-6 alkyl)amino C1-6 alkyl, C1-6 alkyl carbonyl, C1-6 alkyl carbonyloxy, C1-6 alkoxyl carbonyl, carbamyl, carbamyl C1-6 alkyl, C1-6 alkyl carbamyl, di(C1-6 alkyl)carbamyl, aminosulfonyl, aminosulfonyl C1-6 alkyl, C1-6 alkyl aminosulfonyl, di(C1-6 alkyl)aminosulfonyl, C1-6 alkyl sulfonylamino, C1-6 alkyl sulfonyl, C1-6 alkyl carbonylamino or guanidino.
Dependencies are inferred from the claim text.